We are live on ! Find out more
ARTLW

Artelo Biosciences, Inc. Warrant
ARTLW

Delisted

ARTLW was delisted on the 17th of June, 2024.

Back to rankings

5 hedge funds and large institutions have $1.9K invested in Artelo Biosciences, Inc. Warrant in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more funds holding

Funds holding: 3 → 5 (+2)

35% less capital invested

Capital invested by funds: $2.92K → $1.9K (-$1.02K)

Holders
5
Holders Change
+2
Holders Change %
+66.67%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
+$5
2
UBS Group
UBS Group
Switzerland
+$5

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Verition Fund Management
1
Verition Fund Management
Connecticut
$1.32K – – –
AGM
2
Alpine Global Management
New York
$565 – – –
Morgan Stanley
3
Morgan Stanley
New York
$6 – – –
Bank of America
4
Bank of America
North Carolina
$4 +$5 +100 New
UBS Group
5
UBS Group
Switzerland
$4 +$5 +100 New

ARTLW Hedge Fund Activity: Q3 2023 in Review

5 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Artelo Biosciences, Inc. Warrant (ARTLW) for Q3 2023, worth a combined $1.9K — down 35% from $2.92K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new ARTLW positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Bank of America, opening a new position worth an estimated $5.

  • 5 institutional investors held Artelo Biosciences, Inc. Warrant (ARTLW) as of Q3 2023, up from 3 in Q2 2023.
  • Funds reported $1.9K of Artelo Biosciences, Inc. Warrant stock for Q3 2023, down 35% quarter-over-quarter.
  • 2 funds opened new Artelo Biosciences, Inc. Warrant positions in Q3 2023 and 0 closed out, a net change of +2 holders.
  • The largest Artelo Biosciences, Inc. Warrant buyer in Q3 2023 was Bank of America, an estimated $5 added.

Based on aggregated 13F filings for Q3 2023.